Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEED: On Demand vs Continuous Esomeprazole in Endoscopy-Negative GERD
NCT02670642Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2001
- Primary completion
- Nov 2002
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Aug 2001; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02670642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670642.